DGK-β Antibodies

Santa Cruz Biotechnology provides a broad selection of DGK-β monoclonal antibodies for investigating diacylglycerol kinase beta in cellular processes. DGK-β monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DGK-β plays a crucial role in lipid signaling pathways by converting diacylglycerol into phosphatidic acid, thereby regulating various cellular functions such as proliferation, differentiation, and apoptosis. The involvement of DGK-β in cancer biology and other diseases makes it a significant target for therapeutic interventions. Understanding DGK-β function can provide insights into the mechanisms of disease progression and potential treatment strategies. Researchers can utilize DGK-β monoclonal antibodies to explore signaling pathways in both normal and pathological conditions. Advanced detection methods using horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates enable precise visualization of DGK-β localization and interactions. Santa Cruz Biotechnology monoclonal antibodies support the scientific community by enabling detailed investigation of DGK-β's role in cellular regulation and disease development.